Anti BRD4 pAb (ATL-HPA061646)
Atlas Antibodies
- SKU:
- ATL-HPA061646-25
- Shipping:
- Calculated at Checkout
$395.00
Gene Name: BRD4
Alternative Gene Name: CAP, HUNK1, HUNKI, MCAP
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000024002: 97%, ENSRNOG00000006770: 97%
Entrez Gene ID: 23476
Uniprot ID: O60885
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Product Specifications | |
Application | ICC, IHC, ChIP-Exo-Seq |
Reactivity | Human |
Clonality | Polyclonal |
Host | Rabbit |
Immunogen | PPFIATQVPVLEPQLPGSVFDPIGHFTQPILHLPQPELPPHLPQPPEHSTPPHLNQHAVVSPPALHNALPQQPSRPSN |
Gene Sequence | PPFIATQVPVLEPQLPGSVFDPIGHFTQPILHLPQPELPPHLPQPPEHSTPPHLNQHAVVSPPALHNALPQQPSRPSN |
Gene ID - Mouse | ENSMUSG00000024002 |
Gene ID - Rat | ENSRNOG00000006770 |
Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
Documents & Links for Anti BRD4 pAb (ATL-HPA061646) | |
Datasheet | Anti BRD4 pAb (ATL-HPA061646) Datasheet (External Link) |
Vendor Page | Anti BRD4 pAb (ATL-HPA061646) at Atlas Antibodies |
Documents & Links for Anti BRD4 pAb (ATL-HPA061646) | |
Datasheet | Anti BRD4 pAb (ATL-HPA061646) Datasheet (External Link) |
Vendor Page | Anti BRD4 pAb (ATL-HPA061646) |
Citations for Anti BRD4 pAb (ATL-HPA061646) – 3 Found |
Lee, Minji; Tayyari, Farnoosh; Pinnaduwage, Dushanthi; Bayani, Jane; Bartlett, John M S; Mulligan, Anna Marie; Bull, Shelley B; Andrulis, Irene L. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival. Bmc Cancer. 2018;18(1):750. PubMed |
Tonouchi, Erina; Gen, Yasuyuki; Muramatsu, Tomoki; Hiramoto, Hidekazu; Tanimoto, Kousuke; Inoue, Jun; Inazawa, Johji. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific Reports. 2018;8(1):4482. PubMed |
Takagawa, Yuki; Gen, Yasuyuki; Muramatsu, Tomoki; Tanimoto, Kousuke; Inoue, Jun; Harada, Hiroyuki; Inazawa, Johji. miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway. Molecular Therapy : The Journal Of The American Society Of Gene Therapy. 2020;28(6):1494-1505. PubMed |